China Dasheng Biotechnology Company
CDBT · OTC
6/30/2023 | 6/30/2022 | 6/30/2008 | 10/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | – | $0 | -$0 |
| % Margin | – | – | 46.1% | – |
| EBITDA | -$0 | – | $0 | -$0 |
| % Margin | – | – | 35% | – |
| Net Income | -$0 | – | $0 | -$0 |
| % Margin | – | – | 28.5% | – |
| EPS Diluted | -0.024 | – | 0.15 | -0.01 |
| % Growth | – | – | 1,600% | – |
| Operating Cash Flow | -$0 | – | $0 | – |
| Capital Expenditures | $0 | – | -$0 | – |
| Free Cash Flow | -$0 | – | $0 | – |